earlier the panel voted against recommending pfizer boosters for everyone, for those ages 16 and up who are already vaccinated, which is what the biden administration wanted. the fda the white house wanted to roll out the third shots. the biden administration has been trying to push back on the notion that even their talk about boosters put any sort of pressure on the scientists, but there are a lot of folks who disagree. >> there's no question about it. and it's really caused a lot of tension from the interagency side of things. the fda and the cdc to spill out into the public, something that's been a serious point of frustration for white house officials over the course of the last several weeks. now, keep in mind what the white house's public health advisers and the president himself announced on august 18th was that every adult american would be eligible for a booster shot within eight months after their first shot come the week of september 20th. now, there are so many elements of that that ended up not coming to pass. moderna did not have enough information to move forward. what was recommended today by the fda advisory panel was, as you noted, for high-risk

a fda advisory panel approving a plan to offer pfizer booster shots for americans 65 and older first, and to those who are at high risk. the fda leaving the door open for the potential to add other groups incrementally. but up first, 65 and older, suggesting you get the booster six months after that second dose. >>> and on the larger question of boosters for everyone 16 and older, they voted no, saying more data is still needed. of course all of this goes to the cdc next. dr. jha standing by tonight. what likely happens from here, and where to get that booster.o. and what if you had the moderna or johnson & johnson vaccine? i'll ask the doctor. >>> also, the pentagon admitting the deadly zone strike was a, quote, tragic mistake. ten civilians, including seven children were killed in the blast. martha raddatz reporting tonight. also, the chairman of the joint chiefs mark milley and his first public comments about his communications with china in the final days of the trump presidency. what the general said today. >>> tonight in the nation's capitol, the fencing and the warning. this is

. >>> is split decision from an fda advisory panel uncovered booster shots. the experts said for most americans, not yet, but for older folks, yes. natalie brand joins us live from the white house with the reasons for today's big decision. >> reporter: this fda advisory panel really spent the day debating whether or not they had enough data to make a recommendation across all age groups. ultimately, they voted in favor of making the booster shot recommendation for older americans, and those at very high risk, but they did not feel like they had enough information to make a broader recommendation at the moment. >> dr. wharton voted no. dr. fuller voted no. >> reporter: and fda panel voted not to recommend pfizer booster shots for people 16 and older based on the data they have currently. >> i would like to see more data before i recommended for a younger age group. >> reporter: they voted unanimously to recommend a vaccine for individuals 65 and older, and those at high risk. >> i'm really glad that we optimized this vaccine for a third dose, and i plan to go

now, in addition to the fda panel meeting about this. cdc will also be holding meetings next week about this booster. >> trying to narrow down exactly who they think should get it meeting those of what age live in san francisco. dan kerman kron 4 news, thank you, dan. marine county educators and health officials are already trying to figure out how and when their students would get their first shots. >> if the fda approval comes as expected for those kids on october 15th marine county with an open clinics. october 23rd the goal in moraine is to get 75% of children between the ages of 5.11. a covid shot within the first month of eligibility. >> we'll have a series of 3 weekends saturday, sunday saturday, sunday, saturday, sunday for the first doses and, know, be a week off probably around thanksgiving and then another series of to really for the second doses. >> to date. there have been no talks about whetler there could be a mandate for children to be vaccinated in order to go to school center in county. covid vaccines might soon be requ

today fda panel recommended the booster only for higher risk groups.ere's what it means, panel of outside experts seemed frustrated actually with pfizer, say the drug maker did not provide enough information about the safety of the third dose of the vaccine. but panel did unanimously recommend boosters for 65 and older and those considered high risk. >> i think we need to target the boosters right now specifically to the people likely to be at high risk. >> our covid expert from ucsf, dr. peter chen hong says it's likely third doses will be approved for 12 and older just not now. and if you're fully vaccinated, protection is still strong. >> by antibody levels it dropped, t cells, inside the body, architect of the immune system, remains intact regardless. that's why people are staying away from the hospital. >> decision now moves to full fda which typically follows the panel's guidance. >>> is the mayor in hot water or following her own rules? mayor breed is responding to allegations of breaking san francisco's covid rules in unmasked visit to a night

there is also the issue of boosters today in fda panel met to discuss if people should get a third shot and if so, which groups should get approval abc 7 news reporter stephanie sierra joins us live from the newsroom with what that panel decided steph yes deion the panel recommended visors booster for certain high-risk. send people 65 and older six months after receiving their second dose, but rejected it for the general population 16. and older the advisors all agreed more data is needed before that happens. after more than eight hours of deliberations leading up to a unanimous vote an fda advisory panel formally recommended a third pfizer. for certain high-risk groups including adults 65 and older at least six months after receiving their second dose. i think it's reasonable. it's it's thoughtful it doesn't use up vaccines. globally. it's different infectious disease position, dr. jorge salinas investigates measures to prevent covid infections. he agrees with the panel's decision to reject recommending a third visor dose for people 16 and older citing the need for more data they felt

the fda panel unanimously supporting it. meanwhile, the additional shots already going into the arms of the immunocompromised like beth dixon. >> you know, we need to listen to the experts on this. if they're saying that this is really only better for right now for people who are in higher risk categories, then it makes sense it's only available to those categories. i understand that my condition is different from most people who have normal working immune systems. >> reporter: this as the pandemic continues to reach new heights. the u.s. now averaging more than 1,400 deaths a day, approximately 7.5 times higher than in mid-july. with icus in eight states now running out of beds, more than 2,000 of those hospitalized across the country sick with covid are children. in south carolina, 17-year-old christian davila is still struggling to walk a month after contracting the virus. >> right now it's just physical therapy to get back to 100%. covid took all of my stamina away. >> reporter: guys, while critics say the biden administ

breaking tonight, an fda panel rejected the panel for booster shots, but the panel endorsed boosters americans 65 and older and those of high risk of severe disease. sabrina, where does this leave things with the biden administration? the president came out saying we need to get booster shots for all americans that are eligible. this is a much narrower decision, a much narrower recommendation. sabrina: it's a blow to the biden administration because weeks ago, they announced plans to give out boosters to the ameran public in september. and they had said that most americans would be eligible for a booster eight months after they got there second dose. we are now talking about a much smaller subset of the population, although there was some criticism from scientists in the government that the biden administration was pushing boosters. they felt the process has been rushed, that the data isn't there to demonstrate the need for boosters for all americans. they feel like it's more supportive of the idea that people who are immunocompromised, in nursing homes, seniors, more of a need for b

that's the question coming before an fda panel on friday. pfizer makes the case that while its vaccine still protects against severe disease immunity wanes against mild infections after 6 to 8 months. recommend that. >> all the individuals over 60 should be offered of lucerne. i'd recommend that you come rise in the video still continues to get their additional shots. >> ucsf infectious disease specialist doctor peter chin-hong says that recommendation is based on data from israel. however, he says that research still doesn't indicate how long those boosters will last. i'd like to know how long these uses will actually last. >> because that helps me the chairmen tradeoffs in terms of. is it really with while setting up this revolving door, many, many blue serious. if overall. my projection is going to be relatively stable over time and all i'm trying to do is prevents. infection, most of which is miles in the vaccinated. chin-hong says khe current lack of convincing data. >> is what's keeping him from recommending a booster for those under 6

the nation's top doctors defending the fda panel recommendation to limit who should get a covid vaccine booster. >> science playing out in a very transparent way. >> why they think the list of those eligible may soon expand. >>> school shutdowns. more than 2,000 schools have closed already this year due to covid outbreaks. the new protocols some districts are using to stay open. >>> breaking news just moments ago. a body has just been found believed to be that of gabby petito. now her fiance, a person of interest after their cross country trip together has gone missing. >>> a military plane crashes into a texas neighborhood. homes damaged. the pilots rushed to the hospital. >> just black smoke everywhere. >>> why are the fish in the sea getting smaller? what it means for the price you pay at the store. >>> what these two young boys did that meant so much to one veteran's family. >> this is nbc "nightly news" with kate snow. >>> good evening. the images from the small border town of del rio, texas have been disturbing. nearly 15,000 migrants mainly haitian forced to live in miserable liv

on friday an fda panel voted against booster shots for lower risk americans under 65 years old. time last year, cases and hospitalizations begin to crash in the south and start to head north. but thankfully, hospitalizations among the vaccinated still remain very, very low. for more on the fda decision and the state of covid, we're joined now by dr. levy, director of the precisions vaccine program at boston children's hospital and also a voting member of the fda advisory committee that made the vote on friday fantastic to have you back on, dr. levy how did you vote >> always a pleasure good morning to you and your viewers. i voted along with the other members of the committee on the first vote they posed a question to the advisory committee about whether we would endorse a third booster dose of the pfizer mrna vaccine for everyone 16 years of age and up that question received a majority of no as votes. i think around a margin of 17 no to 4 yes and then the question got rephrased. we partnered with fda to rephrase the question for 65 years of age and up, and other individuals at

miguel almaguer has late details >> reporter: tonight the fda panel's dramatic denial. no booster shots for the general public, a safety committee overwhelmingly rejecting a third dose of pfizer's vaccine for most adults. but in an unexpected second vote authorizing its use for those 65 and older and for americans at high risk of contracting severe covid-19 >> we made the decision not to follow israel's lead, which is to just give a third dose period. >> reporter: at the core of today's split decision, clinical research from israel showing vaccine protection from infection does wane after six months, but remains highly effective in preventing hospitalization and serious illness. >> regardless of the vaccines evaluated, all vaccines have remained effective. >> reporter: while it may be too early for most to get a booster, the fda advisory committee agreed a third dose could be used under emergency use authorization. the agency could soon officially recommend a pfizer booster for well over 21 million people >> scientific debate is normal, expected and healthy in the scien

fda independent panel of advisers recking the shots for 65 and older and those at risk for severe infectionpress concerns about the lack of safety data for young adults and the fact that pfizer's data has not yet been reviewed by the fda. joining me now with more dr. nathan, an emergency medical physician in new jersey. good to see you as always. are you satisfied with this decision? >> i'm very reassured by the pu decision and the public should be reassured why it is driven by evidence and science. what the fda independent panel is telling us is that vaccines are extremely effective against preventing severe death and should be a really reassuring message to people and it tells us what the focus is with vaccines covert covid-19 from something that's a life threat to a minor disease. >> so the cdc would have access to the same data, correct? yet they could reach a different conclusion. >> absolutely. this is coming with the interpretation of the data and we haven't seen all the pfizer data. as a farm suit call company they have a speck need. they have a specific want and desire. our desire

. >>> fda advisory panel voted 16-2 against boosters for most americans. the pfizer. the drug maker did not provide enough information about a safety of a third dose of the vaccine. the panel voted yes to recommended boosters for americans 65 and up and those considered high risk. >> we need to target boosters right now to the people who are likely to be at high-risk. >> the decisions move to the full fda. the worldwide debate across the globe about third doses continue. the world health organizations say wealthier country should wait. joining us now is dr. peter hong. hi doctor, thank you for joining us on this friday. a lot of back and forth. the biden administration says yes on boosters and fda says no, only people of 65 and up. what did you think? >> it was unfortunate timing. you get the science then you make the policy, you don't make the policy and look at the science. i think one of my colleagues say, you give the american public the kick and you are taking back the kick from them. the fda was rigorous, they looked to the science and recommendations for three

. >>> "outfront" next, breaking news a key fda panel rejecting president biden's plan to start booster shots for all american adults approving boosters for people 65 and older and those with preexisting conditions. why? more breaking news a cnn defense department official reached out to china on the day of the january 6th insurrection and two days before mark milley did. what he called and what was the message? >>> the fbi joining the search for the 22-year-old missing florida woman on a cross country road trip with her fiancee. he's not talking. a police chief on the case is my guest. let's go "outfront". >>> good evening, i'm erin burnett. breaking news, a major set back for president biden, laid today an fda panel voting to not approve a booster shot forall f all adults, only those 65 and older and at high risk and they voted against authorizing a booster shot for the majority of americans those 16 and older. make no mistake, this is a rebuke for biden and it stands in direct contrast from 30 days ago when he tweeted simple the second shot get your booster shot and he attached this

excited about these things, which i do, which is the discussion from this outside panel of vaccine advisers to the fda about whether we need a booster and who might need a booster and if there's enough data to support approving this pfizer booster shot. and really, the panel appears to not be decided that there needs to be a booster for everybody over age 16. which is the question right now, that they plan to vote on. if you look at the stocks of pfizer and biontech, which are the actual makers of the vaccine that's up in front of the fda today, but also, of moderna. throughout the course of the day, you can see they're down right now and they took a real big plunge just after noon today, when evercorps isi put out a note essentially saying, he doesn't think they're going to vote "yes" on boosters today, based on the way the conversation is going. we're going to have to see how this conversation shakes out but right ow, we are essentially hearing that it looks like they don't think that the safety database is large enough, from what pfizer submitted. there are questions about whether they should depen

we tracked an fda panel meeting today explains her decision. porter: after more than eight hours of deliberations and fda advisory panel formally recommended the third pfizer dose for certain high risk groups, including adults 65 and older at least six months after receiving the second dose. >> it is reasonable, thoughtful, it doesn't use up vaccines globally. reporter: dr. salinas investigates measures to prevent covid infections. he agrees with the pinup's decision to reject recommending a third pfizer dose for people 16 and older, citing the need for more data. >> they felt the potential benefit from added protection of the third dose was probably not strong enough to overcome the potential for increased risk of myocarditis. there is a theoretical risk, probably low. they wanted to give a firm recommendation based on data rather than opinion. reporter: the formal recommendation includes high-risk groups, also those of high risk of occupational exposure may be included. >> if you are at risk of getting infected while at work, that applies to v

the lower effective meant likely include both waiting over time. >> and the delta variant if the fda panel of the plate in 2 how can make sure current. >> since the advisory panel declined to endorse the booster shot for people under 65 a vote will now go before the fda for a final decision. the cdc plus also issue its recommendation on the booster shot its advisory committee meets on wednesday. and if boosters are approved, the biden administration says it will be ready to jump into action. by the way, moderna has developed a separate booster for its vaccine which you claim says 40 times more effective against the delta variant specifically hammack. and back to you. all right. grant, thank you. and coming up at 6.30. we will be joined live by infectious disease expert answer more questions. doctor peter chin hong will join us. >> a new social media challenge is calling on children to vandalize their school bathrooms. a number of schools across the country been reporting damage. but it's also starting to hit schools here in the bay area. kron four's charles clifford has details. platform w

that's the question coming before an fda panel on friday. pfizer makes the case that while its vaccine still protects against severe disease immunity wanes against mild infections after 6 to 8 months. recommend that. >> all the individuals over 60 should be offered of lucerne. i'd recommend that you come rise in the video still continues to get their additional shots. >> ucsf infectious disease specialist doctor peter chin-hong says that recommendation is based on data from israel. however, he says that research still doesn't indicate how long those boosters will last. i would like to know how long these uses will actually last. >> because that helps me the chairmen tradeoffs in terms of. is it really with while setting up this revolving door, many, many blue serious. if overall. my protection is going to be relatively stable over time and all i'm trying to do is prevents. infection, most of which is miles in the vaccinated. chin-hong says the current lack of convincing data. >> is what's keeping him from recommending a booster for those und

. >> we know an fda panel is going to be talking about the pros and cons and who might get a third boosterd who might not need one. we'll tell you what's on the table. you're watching "today in the bay." oh! my new, bigger, crispier cluck sandwich. mmh. just tell me you're not going to go overboard with the marketing. no. you're fully clucked out, aren't you? try my $6.99 cluck sandwich combo. download the jack app today. >>> right now at 5:30, do you need one or not? a crucial meeting on covid booster shots and what infectious disease experts believe will happen in just hours. >>> whistleblower testimony. a former theranos employee heads back to the stand in the elizabeth holmes' criminal fraud style. what we expect from today's hearing. >> i hear the howling at night. >> not your average neighborhood watch. the wild with encounters that have one community taking action. this is "today in the bay." >>> this is friday morning. thanks for starting your day with us. i'm laura garcia. >> i'm marcus washington. all right. time to get a look at that friday forecast. meteorologist kari hall is s

we tracked an fda panel meeting today explains her decision. reporter: after more than eight hours of deliberations and fda advisory panel formally recommended the third pfizer dose for certain high risk groups, including adults 65 and older at least six months after receiving the second dose. >> it is reasonable, thoughtful, it doesn't use up vaccines globally. reporter: dr. salinas investigates measures to prevent covid infections. he agrees with the pinup's decision to reject recommending a third pfizer dose for people 16 and older, citing the need for more data. >> they felt the potential benefit from added protection of the third dose was probably not strong enough to overcome the potential for increased risk of myocarditis. there is a theoretical risk, probably low. they wanted to give a firm recommendation based on data rather than opinion. reporter: the formal recommendation includes high-risk groups, also those of high risk of occupational exposure may be included. >> if you are at risk of getting infected while at work, that applies to

the fda panel here recommending a booster shot for those 65 and older as well as those who might be inardous work conditions, those first responders that might benefit from this extra dose of immunity. from the white house's perspective obviously there's some confusion here, but they're making the case their job all along is to be prepared for whatever the science leads them to. they're ready for unveiling more of these booster shots, putting them out if needed. but obviously at this point there's still time before that for the general public. >> joining me now to further discuss professor at the boston school of medicine and msnbc medical contributor. what -- as i welcome you, my friend -- what is your take on the fda's decision and how far might this go to dispel those who don't want to get vaccinated because they say, oh, we don't know enough about it? i mean to listen to the carefully scrutiny in this discussion it shows that the fda is taking this extremely seriously. they're not just like stamp of approval on it. >> that's right, alex. and what a difference from about a year ago

the panel voting to approve third dose for anyone at risk of severe covid. the fdainto consideration but will issue a final decision in days. the white house saying the administration stands ready to provide boosters to eligible americans once the review process finishes. boosters will be given in stages starting with those 65 and older and those at high risk. for the second day in a row, it states icus at 90% capacity. marissa's husband is on a ventilator. i thought it was a huge joke and obviously it is not because my husband is laying next to me. reporter: president biden will hold a summit on covid-19 with other world leaders amid the u.n. general assembly. amanda:'s's not to the nation capital. authorities are warning of violence ahead of a rally in support of those charged in the january 6 right is expected today. rachel has more. reporter: washington, d.c.'s police chief once they have picked up chatter about possible violence and they are taking no chances. we sought beefed-up security and new surveillance cameras. >> we have a plan in place to ensure it rem

if the fda panel of the plate in 2 how can make sure current. >> doctor david wiseman who led the research clinical trials for the johnson. johnson vaccine question. the science behind pfizer's data bill, short term. there is no randomized control. there are no clinical outcome baker the advisory panel declined to endorse the booster shot. so we vote will now head to the fda for a final decision and if the boosters are approved, the biden administration says they're ready to jump into action. yesterday the cdc sent a message. >> the state health officers laying out the process ahead and offering to help implemented in their jurisdiction. >> the cdc must also give their recommendation on the booster shot. their advisory committee is scheduled to meet on wednesday in washington. i'm anna wiernicki. back to you. >> thank you. and now to another developing story in the nation's capital this weekend. law enforcement is beefing up security in the nation's capital following threats of violence at tomorrow's j 6 rally. the far right group is calling for justice for those jailed after storming the

advisory vote health experts fiercely divided over whether boosters are needed on the eve of that fda panel meeting to decide whether to recommend them will the fda meet president biden's timeline to roll out boosters just days from now >>> and hospitals in crisis where they are now rationing care statewide. >>> also tonight, tracking severe stormsning flash floods around d.c. some areas getting an inch of rain in just 20 minutes >>> alex murdaugh surrendering to police, the south carolina attorney accused in a bizarre suicide-for-hire plot. what happened at his first court appearance late today >>> new body cam of a 22-year-old woman and her fiance weeks before she disappeared on a cross-country trip what it shows. >>> border showdown. the governor of texas demanding border crossings shut down as thousands of migrants wait under a bridge to be processed. and the heartbreaking image of baby and toddler found abandoned. >>> the first all-civilian crew orbiting the earth inside spacex's historic mission >>> the holiday shopping crunch arriving early >>> and "rolling stone" updating its list o

we're seeing in del rio, texas, the drone strike that killed afghan civilians as well as children, fda panelted the administration's booster plan, possible infrastructure vote delay. aoc has thrown up a roadblock on that one, and the looming debt ceiling battle that republicans say they're not going to contribute with. this is why i don't run for president. >> this is why? >> that's the only reason? >> i was just about to say, i wish you woke up as president this morning. >> no, i don't. this is a lesson for all of us considering running for pres president. >> this is why the job is what it is, the big problems end up on the president's plate, and quite frankly, joe biden's political standing is going to be determined by a lot of how this stuff on that list shakes out. it is a mountain of headaches, but that's the job he signed up for. >> as we look ahead to his speech at the unga this week, just detail, put a point on it, the importance of this speech ahead of his meeting with world leaders. >> remember, joe biden sort of sold himself to the american people in part on his foreign policy cre

confusion over booster shots and the fda panel surprise recommendation only those over 65 and at a high-risk for covid get that extra dose. >>> the next steps for full approval for the boosters and we get answers to the questions so many have. >> why the number 65 and older? why not 60 or 50 >>> crisis at the border the new plan for the u.s. to deport thousands of mainly haitian migrants being held in texas and the surge of federal agents heading in. >>> capitol hill on lockdown today, but the police outnumber the protesters. >>> families of those killed in that kabul drone attack speak out to nbc news after the pentagon says the strike was a mistake. what they are demanding. >>> back to earth. the first fully civilian crew in space returns today. their historic splash-down. >>> the massive police search for the fiance of the woman who went missing on their cross-country trip he's now a person of interest and has gone missing too. >>> pet care crisis. almost every state seeing a shortage of veterinarians. pet owners seeking care turned away what you need to know. >>> and the families who wen

countries have even had a first dose will put that in jeopardy. >> so we are continuing to monitor that fda panel decision, which is set to wrap up this afternoon. the cdc, by the way, they have their own vaccine advisory panel. they are set to meet on the same matter next week, and we will monitor that for you as well. >>> well, a clarification now for you, despite earlier reports contra costa county's health officer says he does not plan to recommend all students 12 and up and all schools in the county be fully vaccinated. said that the countywide recommendation would be considered. the county's health officer says he does support west contra costa unified, considering that requirement for any student 12 and older to get vaccinated. staff and teachers would also have to be fully vaccinated. the consequences for not getting vaccinated are still being discussed. oakland unified tells us that they are considering similar rules and could be up for a vote as soon as next week. >>> meanwhile, san francisco mayor london breed facing some scrutiny. this is after being spotted inside a crowded night clu

an fda panel is recommending the booster for some americans. the panel of outside experts says pfizer did not provide enough information about the safety of a third dose of the vaccine for people 16 and older, but the panel did unanimously recommend boosters for americans 65 and older. and those considered at high risk. >> i think we need to target the boosters right now, specifically to the people who are likely to be at high risk. >> the decision now moves to the full fda, which typically does follow the panel's guidance. >>> in an effort to reach underserved communities in san francisco, the city has opened four new vaccination sites. the locations are at malcolm-x academy school in the bayview, balboa high school in the excelsior. those opened this week. clinics in richmond and the sunset elementary school in the sunset will open this weekend. the vaccine sites will prioritize families and staff within the san francisco school district, but everyone 12 and older is welcome. walk-ins are also welcome. the clinics will run through mid-novembe

that's more than the number of people in the united states, and the fda expert panel basically voted e political pressure that the fda's been under saying that there's insufficient data. >> jon: it sounds like this is a case where the science is actually winning out over the politics. >> it is an inspiring moment for science to see scientists push back and say look, this is not the way the process works. you don't buy the vaccine, tell us it is going to be needed and prepare the public and create this expectation without the data being there. my fear, jon, is that it's distracting from our message right now, where we've got to be united and let non-immune adults, adults without vaccination immunity or natural immunity to get vaccinated quickly as delta rips through that segment of the population. those are the people dying right now. >> jon: as you all know, joe biden ran for president saying he had a plan to beat the coronavirus. it sometimes seems like the administration is just kind of winging it. >> well, it has been very frustrating to see mistake after mistake distracting from o

booster shots for a few, not for most of americans that is the reformation from an fda panel. we will get the news. we will gereaction. be right back. >>> all right, you have a disturbing scene in new york city, the fall-out from those who politicized vaccines in this country, this is what happens at the well known carmine's restaurant, asked people from texas for proof of vaccination. under the cdc guidelines. >> my god! [ bleep ] you. >> by the way, the three texas visitors were arrested. the hostess treated for injuries. an fda panel delivered a stinging blow to the white house, to get booster shots to all americans, not to overwhelming recommends against boosters to everyone, and over vaccine policy, the u.s. topped 42 million cases of covid a couple of hours ago. joined by, the dr., give me your reaction to the fda vote? >> well, i think they made the best effort to consider the data. a few things they didn't give adequate attention to, cognitive declines we are seeing, if i were there, i would have pushed my hand to lower the age cut off for recommending the, i would hav

the panel's recommendation is by no means binding for the fda, but it's unlikely they'll move forward with boosters for most americans. they did not consider the moderna or johnson and johnson vaccines for. they had planned to roll out booster shots broadly next week. we have plenty of supply of all three vaccines, um, for boosters pending. now, the white house is facing accusations of getting ahead of the science vaccinations have been central to the president's plan to beat the virus, even though the panel suggests boosters for many may not be needed yet they do say vaccination is important. i don't think a booster dose. is going to significantly contribute to controlling the pandemic. a cdc advisory panel is expected to take on booster shots next week. they'll be looking at the extra shots for those who are older in nursing homes and frontline workers in washington. lauren blanchard, fox news. and earlier this evening we spoke with dr bernice saying clinical professor at stanford to get her thoughts about today's decision by the fda advisory panel. she said she believes that the pa

i think the fda panel got the science right today. the data from israel really does show that the group at highest risk are older americans, although i think most people think they should have come out in favor of extra doses for people over the age of 60. my guess is that as we start to see younger people get past five, six, seven, eight months after their second dose, we'll start to see more evidence for boosters in that group. most of the people in this country were vaccinated in the late spring, so there isn't a lot of reason to vaccinating them now. >> in long haul covid, the mental decline, do you agree with that? >> i think we need more data. another shortcoming of the last year is despite a massive amount of infection in the united states right now amveraging 150 thousa 150,000 cases a day we don't have the data, vaccine specific data. we don't have necessarily a lot of the specific age data. for that reason, the fda panel today relied on a group of israeli experts because they do have the data. i'm hoping over the next few mo

fda advisory panel overwhelmingly voted against a proposal to give a third pfizer covid vaccine dosegeneral population. the booster shot was only approved for seniors or high risk groups. >>> and finally, france recalled its ambassador to the united states in protest over president biden's decision to provide nuclear-powered submarines to australia. the headlines coming within an hour comes just as the white house was hoping for a reset for the president after a tough august dominated the the tumultuous afghanistan pull-out and rising prices. this was to be a time to pivot back to his domestic agenda which as we will discuss shortly, has been jeopardized by members of his own party. this is also a moment in which the white house aides discussed after the u.n. this week curtailing biden's travel, for fear of the president who received his second dose in january could risk exposure to the virus. mike memoli, thank you for being here. let's start with the u.n. speech. what are your sources telling you as to what the president's message will be to the general assembly tomorrow? and how m

now, as we said, we don't yet know what the fda panel will decide, but in an interview with my colleague craig melvin, dr. anthony fauci says that he expects the panel to give the green light in some form. >> let's start with this fda meeting that is happening right now. are you expecting pfizer booster shots to be approved? >> you know, i don't want to get ahead of the fda deliberations. the data i have seen strongly suggests that is going to be the case, but the fda with their advisory group, the verpac is going to carefully look at every single piece of data to make that determination. the age has not been determined, and that is what they are actually discussing now. it could be a broad range. it could be anyone from 18 or 16 or 18 or older or individuals who are elderly or people down to a certain age, 50, 40, 30, and we don't know that right now. that is what is actually being deliberated as you and i are speaking. >> all right. so joining us to start the hour we have nbc correspondent shaquille brewster from baton rouge, louisiana, and nbc correspondent chris jansing from raleigh,

so lots of people are anticipating what the fda panel will decide on friday.also heard from pfizer tonight the company saying new data shows booster shots may be needed six months after primary doses. and that is the president's plan called for eight months after your second dose. raj? >> sergio, thank you. we'll continue to try to iron out this confusion. >>> just in tonight, it would be one of the first vaccine mandate for middle and high school students in the east bay. here's what we know. the west contra costa unified school board will vote on this issue at a special meeting next week. under the proposal, students 12 and older would have to be fully vaccinated by october 31st, by halloween. if not, those students will have to switch to remote learning. this includes el cerrito, richmond and pinole valley high schools. >>> also tonight, marin county is gearing up to offer a covid vaccine for children ages 5 to 11. but first, they need that green light from the fda and cdc. that approval of the children's pfizer vaccine is expected late next month. the goal

coming up in the next hour, a panel of fda advisers pulls back on the idea of boosters for all, instead, backing boosters for a smaller group of more vulnerable people. what does it mean? we will dig in. plus, 360 miles above the earth. four civilian astronauts are near the end of an epic journey. we will get an update. is holding elizabeth holmes accountable sexist? the under -- the author of a controversial piece joins us. you will recognize her name. the project includes ceo ellen powell was us now. first, a look at the markets with ed ludlow. i see a lot of red at the end of the week. welcome. ed: if you times of the year, you see index and equity options expiring. and, high-volume as a result. you see the s&p 500 down 9/10 of 1% and technology the under performer. the nasdaq 100 biggest drop since may. there is a little weakness in semiconductors as well. down 1.5%. really interesting moves in the cryptocurrency space. the bloomberg crypto index is down significantly, 2%. you see bitcoin lower at the moment. it has been up for most of the day. it was interesting to see the broader

kumasi: an fda panel is set to vote on recommendations for pfizer's shot, as the delta variant keepssed yesterday made the case for booster shots people 16 and up. you need to get the shot six months after your second dose. companies also suggesting the reduction in vaccine protection is not due to the strength of the delta variant, but due to the decrease of the vaccine's effectiveness. >> this is not directly related to delta, but just because of waning immunity. this is why the booster question is coming into play right now. kumasi: a review of moderna's booster shot will happen in the coming weeks. the company says people who received its vaccine will also need a third dose after six months, but unlike pfizer, modernity booster shot will be a half dose, which the -- moderna's booster shot will be a half dose, which the company says and provides enough protection. reggie: vaccine clinics for ages five to 11 are being opened up, even though the vaccine has not been approved for that age group yet. amy hollyfield joined us on where they are getting such an early start. amy: here at

panel is set to meet. any final decision from the fda and the cdc won't come until after that. so, bottom line here tonight, what's the guidance on the timeline, where it stands right now? >> reporter: david, the final step in this process has to go through that cdc panel and they're not expected to meet until next wednesday, so boosters likely won't be available to the public until late next week at the earliest and if they are approved, the white house says they're ready to roll out those shots at 80,000 locations across the country. david? >> all right, whit johnson tonight. whit, thank you so much. i know many of you at home have questions about the potential for boosters on the way. so, let's bring in dr. ashish jha, dean of the brown university school of public health. dr. jha, always great to have you with us. let's get right to what the fda released today, this pfizer data. they're now suggesting this extra dose, this booster shot, a third shot, for those 16 and older, about six months after receiving that second dose. and they said this isn't necessarily because of the

fda decision. today was just the advisory panel. , but they usually. do the cdc committee will also meet next week and then we will get a cdc decision on this matter. so we will see what happens from here. but in terms of why the expectations of the media today were so different than public experts we expectations, i'm interested in. that i'm also interested in how well supported by the data these decisions today were. i know just the person to. ask joining us now is doctor xi 's john, he is the dean of brown university school of. health thank you for joining us tonight. >> hello rachel, thanks for having me back. >> is it correct to say that these decisions today were broadly expected in the public health community even though, and a lot of the, media they were treated as surprising developments? >> absolutely. you've got that completely. right i think all of us predicted that this is exactly what would happen because we've all been looking at the science and the data for high-risk people over 65 is clear. so we expected the fda com

the fda will consider the panel's advice on boosters, then make its own decision. and the cdc is also expected to weigh in within days. >>> returning to texas and next year's race for governor there, a new poll shows dropping support for republican governor greg abbott. his approval rating now 45% and the same "dallas morning news" poll shows actor matthew mcconaughey with a nine-point lead over abbott in a hypothetical matchup. and former democratic congressman and presidential candidate beto o'rourke trails in a hypothetical race. >>> coming up, new gadgets just in time for your fall travel. >>> plus the wild night in baltimore with the qb flipping into the end zone. >>> but first the bus crash that left 32 people injured. many of them high school students. that's next. you're watching "world news now." do you have a life insurance policy you no longer need? now you can sell your policy, even a term policy, for an immediate cash payment. we thought we had planned carefully for our retirement. but we quickly realized that we needed a way to supplement our income.

the fda panel simply decided today to give priority to the high risk groups. so what happens next with the fda will consider the panel's recommendation and then make its own decision probably within the next several days. the cdc will be weighing in on the matter next week. we'll keep you posted there, ken and pam, back to you. all right. grant, thank you for that. moderna meantime, has developed a separate booster for its vaccine which it claims is 40 times more effective against the delta variant, a cdc study of all 3 authorized covid vaccines found that moderna shot is slightly more effective at preventing hospitalizations. moderna came in at 93%. pfizer 88% and johnson and johnson. 71%. however, researchers stress. all 3 vaccines provide substantial protection. the study looked at patients in 21 hospitals across 18 states for the study. they also examined antibodies in the blood of a 100 healthy volunteers after they had gotten one of the 3 available shots. >> san francisco mayor london breed is not apologizing tonight. she was caught on camera without a m

advisors on the fda panel are debating the issue right now. there's a live look at their zoom call. they're weighing evidence from the uk and israel, which shows that boosters are necessary because of waning immunity. >> now, the advice is not unanimous. two departing high-level fda scientists say a booster shot is not needed at this time. president biden's covid response team had planned to begin distributing boosters next week, but even if this fda panel signs off, another approval must come from the cdc. president biden's chief medical advisor, dr. anthony fauci, today suggesting approval is likely. >> the data that i have seen, i believe strongly suggests that will be the case. our position about at least planning for the eadventureuation that we might have to give boosters, we vernal have planned very ready to go, pending the decision that's made from a regulatory standpoint. >> cnn's senior medical correspondent, elizabeth cohen is here to explain the arguments for or against boosters, so elizabeth, what are you learning from the meeting today? >> alisyn, this issue is so hotl

jillian: and fda panel backs booster shots for older and high risk americans but they believe >> the place that might still be somewhat he questionable will be the very youngest individuals, is the benefit-risk needed there but i believe there will be a decision in the coming weeks to extend boosters beyond the liss not approved on friday. jillian: -- list they approved on friday. jillian: they will make their own recommendations on booster shots this week. todd: seth rogan got the emmy's started, calling out the shortcomings of the covid protocols. >> let me start by saying there is way too many of us in this little room. what are we doing? they said this was outdoors. it's not. [laughter] >> they lied to us. we're in a hermetically sealed event right now -- tent right now. jillian: the host pushed back, saying all guests were required to be vaccinated. but online social media users blasted the lack of masks and social distancing. let's go to week two of the nfl, tom brady throwing five touchdown as the bucs beat falcons. the buffalo bills defense dominated the dolphins with their f

six months after the second shot an fda panel did not give the ok for anybody over the age of 16. >>we want to make sure we are following the right science. timing is everything. reporter: this as they debate the current need for the booster. many agree that the key to battling the virus is to vaccinate the unvaccinated. they are rapidly filling up the hospitals. west virginia hit a new hot record in covid infections. the governor issuing a warning. >> we will run to the fire and get vaccine at right now or we will pile the body bags up. . reporter: they have case rates up to 500 per 500,000 people. montana is calling in the national guard for the search. >> when all these people who are unvaccinated die and wish they got it, it is wary. it makes us angry. reporter: some hospitals experiencing critical shortages as they feel like they are underwater, drowning as a wave of patients sick with covid crashes in. >> this is breaking all of us. reporter: the rise in cases pushing back surgeries. the seven-year-old with cerebral palsy was scheduled to get a feeding tube. that surgery is now

fda decision next week. today was just the advisory panel, and the fda isn't required to accept the advisory panel's recommendationst next week, and then we will get a cdc decision on this matter. so we'll see what happens from here, but in terms of why the expectations in the media today were so different than public health experts' expectations, i'm interested in that. i'm also interested in how well supported by the data these decisions today were. i know just the person to ask. joining us is dr. ashish jha. thank you for making time tonight. i appreciate you being here. >> hello, rachel. thanks for having me back. >> is it correct to say that these decisions today were sort of broadly expected in the public health community even if in a lot of the media they were treated as very surprising developments? >> absolutely. you have got that completely right. i think all of us predicted this is exactly what would happen because we've all been looking at the science and we've been looking at the data. the data for high-risk people, for people over 65 is clear. we expected the fda advisory committee to say as much. the